Cleared Traditional

K050207 - BD POSIFLOW POSITIVE DISPLACEMENT VALVE

K050207 is an FDA 510(k) clearance for BD POSIFLOW POSITIVE DISPLACEMENT VALVE, manufactured by Becton Dickinson Infusion Therapy Systems, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 69-day FDA review.

K050207 · Becton Dickinson Infusion Therapy Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2005
Decision
69d
Days
Class 2
Risk

K050207 is an FDA 510(k) clearance for the BD POSIFLOW POSITIVE DISPLACEMENT VALVE. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Becton Dickinson Infusion Therapy Systems, Inc. (Sandy, US). The FDA issued a Cleared decision on April 7, 2005 after a review of 69 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton Dickinson Infusion Therapy Systems, Inc. devices

FDA 510(k) Submission Details - K050207

510(k) Number K050207 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 28, 2005
Decision Date April 07, 2005
Days to Decision 69 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 129d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 812
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K050207.
MINILOC SAFETY INFUSION SET
K050600 · Specialized Health Products, Intl. · May 2005
PENTADEFLUE IV SOLUTION ADMINISTRATION SETS
K041495 · Pentaferte S.P.A · Apr 2005
MICROFLO-SAFE SCALP VEIN SET
K043328 · Dks Loversan Industria Biomedica Spa · Apr 2005
DRAGON HEART I.V. SET
K043235 · Dragon Heart Medical Devices Co., Ltd. · Mar 2005
F00010 - IV GRAVITY SETWITH MALE LUER SLIP
K042129 · Cedic S.R.L. · Jan 2005
LUTH-ALL SUB-Q NEEDLE SET
K042666 · Luth-All Medical Products, LLC · Dec 2004